BioCardia (BCDA) Short Interest Ratio & Short Volume $2.25 0.00 (0.00%) As of 02:11 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioCardia Short Interest DataBioCardia (BCDA) has a short interest of 23,100 shares, representing 0.60% of the float (the number of shares available for trading by the public). This marks a -66.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 262,081 shares to cover all short positions.Current Short Interest23,100 sharesPrevious Short Interest68,600 sharesChange Vs. Previous Month-66.33%Dollar Volume Sold Short$49.90 thousandShort Interest Ratio0.3 Days to CoverLast Record DateMay 31, 2025Outstanding Shares5,178,000 sharesFloat Size3,820,000 sharesShort Percent of Float0.60%Today's Trading Volume79,676 sharesAverage Trading Volume262,081 sharesToday's Volume Vs. Average30% Short Selling BioCardia? Sign up to receive the latest short interest report for BioCardia and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCDA Short Interest Over TimeBCDA Days to Cover Over TimeBCDA Percentage of Float Shorted Over Time BioCardia Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202523,100 shares $49.90 thousand -66.3%0.6%0.3 $2.16 5/15/202568,600 shares $159.15 thousand -49.9%1.8%0.8 $2.32 4/30/2025137,000 shares $430.18 thousand +243.4%3.7%1.8 $3.14 4/15/202539,900 shares $81.80 thousand -24.4%1.1%0.6 $2.05 3/31/202552,800 shares $134.11 thousand +5.6%1.4%0.8 $2.54 3/15/202550,000 shares $130 thousand +111.0%1.4%1 $2.60 2/28/202523,700 shares $47.64 thousand -57.8%0.7%0.5 $2.01 2/15/202556,200 shares $159.61 thousand +4.7%1.5%1.2 $2.84 1/31/202553,700 shares $132.64 thousand +67.3%1.4%1.1 $2.47 1/15/202532,100 shares $71.26 thousand -36.3%0.8%0.6 $2.22 Get the Latest News and Ratings for BCDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioCardia and its competitors with MarketBeat's FREE daily newsletter. 12/31/202450,400 shares $109.87 thousand -39.6%1.3%1 $2.18 12/15/202483,400 shares $173.47 thousand -19.5%2.2%1.5 $2.08 11/30/2024103,600 shares $236.21 thousand -5.4%2.9%1 $2.28 11/15/2024109,500 shares $202.58 thousand +26.9%3.1%0.1 $1.85 10/31/202486,300 shares $201.08 thousand +72.6%3.2%0.1 $2.33 10/15/202450,000 shares $122 thousand -62.2%1.8%0.1 $2.44 9/30/2024132,100 shares $412.15 thousand -12.6%4.8%0.2 $3.12 9/15/2024151,200 shares $449.06 thousand -91.7%6.4%0.2 $2.97 8/31/20241,830,000 shares $5.58 million +2,719.7%84.3%2.3 $3.05 8/15/202464,900 shares $188.21 thousand +104.1%4.3%0.4 $2.90 7/31/202431,800 shares $95.72 thousand +8.2%2.5%0.2 $3.01 7/15/202429,400 shares $104.08 thousand -38.8%2.3%0.2 $3.54 6/30/202448,000 shares $142.56 thousand -37.7%3.7%0.4 $2.97 6/15/202477,100 shares $262.91 thousand +267.1%6.0%0.6 $3.41 5/31/202421,000 shares $97.02 thousand -91.1%1.6%0.2 $4.62 5/15/2024235,400 shares $92.04 thousand -10.4%N/A0.7 $0.39 4/30/2024262,800 shares $101.73 thousand -3.1%N/A0.8 $0.39 4/15/2024271,200 shares $100.99 thousand -49.4%N/A0.8 $0.37 3/31/2024535,900 shares $218.11 thousand -46.9%N/A1.4 $0.41 3/15/20241,010,000 shares $393.90 thousand +927.5%6.2%2.7 $0.39 2/29/202498,300 shares $54.07 thousand -67.0%0.7%0.3 $0.55 2/15/2024297,600 shares $127.97 thousand +84.2%2.5%1 $0.43 1/31/2024161,600 shares $73.24 thousand +22.8%1.3%0.1 $0.45 1/15/2024131,600 shares $85.33 thousand -39.2%1.1%0 $0.65 12/31/2023216,600 shares $143.87 thousand -31.8%1.8%0.1 $0.66 12/15/2023317,800 shares $191.00 thousand -9.0%2.7%0.1 $0.60 11/30/2023349,100 shares $216.86 thousand +132.0%3.5%0.1 $0.62 11/15/2023150,500 shares $142.22 thousand +13.4%1.5%0.1 $0.95 10/31/2023132,700 shares $49.40 thousand -35.2%1.3%1.2 $0.37 10/15/2023204,900 shares $90.16 thousand +9.8%2.1%1.5 $0.44The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 9/30/2023186,600 shares $80.22 thousand +48.1%1.6%1.4 $0.43 9/15/2023126,000 shares $49.77 thousand -36.7%1.1%0.9 $0.40 8/31/2023199,000 shares $155.22 thousand +8.0%1.7%1.8 $0.78 8/15/2023184,300 shares $162.15 thousand +575.1%1.5%1.9 $0.88 7/31/202327,300 shares $28.12 thousand -84.0%0.2%0.3 $1.03 7/15/2023171,000 shares $398.43 thousand -14.2%1.4%2.4 $2.33 6/30/2023199,400 shares $532.40 thousand -4.3%1.6%5.1 $2.67 6/15/2023208,300 shares $477.01 thousand +3.8%1.6%5.6 $2.29 5/31/2023200,600 shares $355.06 thousand +1,443.1%1.6%6.9 $1.77 5/15/202313,000 shares $24.05 thousand -29.4%0.1%0.5 $1.85 4/30/202318,400 shares $37.90 thousand -12.0%0.1%0.9 $2.06 4/15/202320,900 shares $40.96 thousand -23.7%0.1%0.9 $1.96 3/31/202327,400 shares $53.43 thousand -26.9%0.2%1 $1.95 3/15/202337,500 shares $73.88 thousand +4.8%0.3%1.2 $1.97 2/28/202335,800 shares $78.76 thousand +96.7%0.3%0.7 $2.20 2/15/202318,200 shares $40.59 thousand -56.6%0.1%0.4 $2.23 1/31/202341,900 shares $106.43 thousand -4.3%0.3%0.9 $2.54 1/15/202343,800 shares $100.30 thousand -15.4%0.4%1 $2.29 12/30/202251,800 shares $108.26 thousand -40.6%0.4%1.2 $2.09 12/15/202287,200 shares $149.11 thousand +149.1%0.7%2 $1.71 11/30/202235,000 shares $64.75 thousand +44.0%0.2%0.8 $1.85 11/15/202224,300 shares $45.68 thousand -42.1%0.2%0.5 $1.88 10/31/202242,000 shares $81.90 thousand -24.5%0.3%0.7 $1.95 10/15/202255,600 shares $116.20 thousand -37.3%0.4%0.9 $2.09 9/30/202288,600 shares $171.88 thousand -7.2%0.7%1.4 $1.94 9/15/202295,500 shares $193.87 thousand -2.7%0.7%1.6 $2.03 8/31/202298,100 shares $195.22 thousand +182.7%0.7%1.4 $1.99 8/15/202234,700 shares $58.30 thousand -42.1%0.3%0.7 $1.68 7/31/202259,900 shares $86.86 thousand -25.7%0.5%1.2 $1.45 7/15/202280,600 shares $124.93 thousand -47.7%0.8%1.2 $1.55 6/30/2022154,200 shares $223.59 thousand -29.3%1.6%0.2 $1.45 6/15/2022218,100 shares $307.52 thousand -42.2%2.3%0.3 $1.41 5/31/2022377,300 shares $633.86 thousand -2.8%2.9%0.6 $1.68 5/15/2022388,200 shares $543.48 thousand -38.1%3.0%0.6 $1.40 4/30/2022627,000 shares $965.58 thousand -49.8%5.0%0.7 $1.54 4/15/20221,250,000 shares $1.86 million +150.1%10.0%0.7 $1.49 3/31/2022499,900 shares $1.03 million -5.7%4.0%0.4 $2.07 3/15/2022530,100 shares $1.03 million -10.4%4.2%0.4 $1.95 2/28/2022591,700 shares $1.22 million -45.2%4.7%0.4 $2.07 2/15/20221,080,000 shares $2.39 million +425.3%8.5%0.8 $2.21 1/31/2022205,600 shares $380.36 thousand -7.3%1.6%0.2 $1.85 1/15/2022221,700 shares $390.19 thousand -13.8%1.7%1.5 $1.76 12/31/2021257,300 shares $499.16 thousand +57.5%2.0%1.8 $1.94 12/15/2021163,400 shares $281.05 thousand -30.9%1.3%1.2 $1.72 11/30/2021236,300 shares $484.42 thousand -10.0%1.9%1.7 $2.05 11/15/2021262,600 shares $643.37 thousand -10.5%2.1%1.9 $2.45 10/29/2021293,300 shares $821.24 thousand +3.8%2.3%2.1 $2.80 10/15/2021282,700 shares $828.31 thousand +8.7%2.2%2 $2.93 9/30/2021260,000 shares $816.40 thousand +33.2%2.0%1.8 $3.14 9/15/2021195,200 shares $554.37 thousand -0.9%1.5%1.4 $2.84The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 8/31/2021197,000 shares $581.15 thousand -34.0%1.6%2.8 $2.95 8/13/2021298,300 shares $924.73 thousand +5.3%2.3%4 $3.10 7/30/2021283,400 shares $940.89 thousand -13.8%2.2%3.8 $3.32 7/15/2021328,900 shares $1.11 million -10.7%2.6%4.2 $3.36 6/30/2021368,200 shares $1.46 million +2.1%2.9%4.2 $3.97 6/15/2021360,500 shares $1.60 million -20.0%2.8%3.4 $4.43 5/28/2021450,400 shares $1.84 million +4.9%3.6%4.3 $4.09 5/14/2021429,300 shares $1.43 million +2.0%N/A3.6 $3.32 4/30/2021420,900 shares $1.49 million -0.2%N/A2.6 $3.54 4/15/2021421,900 shares $1.73 million -7.9%N/A1.8 $4.09 3/31/2021458,300 shares $1.82 million +68.4%N/A1.5 $3.98 3/15/2021272,200 shares $1.09 million +25.3%N/A0.5 $4.00 2/26/2021217,300 shares $873.55 thousand +0.5%N/A0.1 $4.02 2/12/2021216,200 shares $1.08 million -63.5%N/A0.1 $4.98 1/29/2021591,600 shares $2.48 million -33.8%N/A0.2 $4.20 1/15/2021894,200 shares $3.35 million +49.8%N/A0.2 $3.75 12/31/2020597,100 shares $2.10 million +4,715.3%N/A0.2 $3.52 12/15/202012,400 shares $55.55 thousand +9.7%N/A0 $4.48 11/30/202011,300 shares $26.56 thousand -6.6%N/A0.2 $2.35 11/15/202012,100 shares $26.26 thousand -57.4%N/A0.2 $2.17 10/30/202028,400 shares $58.22 thousand +3.7%N/A0.3 $2.05 10/15/202027,400 shares $64.66 thousand -9.9%N/A0.3 $2.36 9/30/202030,400 shares $69.01 thousand +237.8%N/A0.3 $2.27 9/15/20209,000 shares $21.38 thousand -61.9%N/A0 $2.38 BCDA Short Interest - Frequently Asked Questions What is BioCardia's current short interest? Short interest is the volume of BioCardia shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 23,100 shares of BCDA short. 0.60% of BioCardia's shares are currently sold short. Learn More on BioCardia's current short interest. What is a good short interest percentage for BioCardia? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.60% of BioCardia's floating shares are currently sold short. Is BioCardia's short interest increasing or decreasing? BioCardia saw a drop in short interest during the month of May. As of May 31st, there was short interest totaling 23,100 shares, a drop of 66.3% from the previous total of 68,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioCardia's float size? BioCardia currently has issued a total of 5,178,000 shares. Some of BioCardia's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioCardia currently has a public float of 3,820,000 shares. How does BioCardia's short interest compare to its competitors? 0.60% of BioCardia's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioCardia: Mersana Therapeutics, Inc. (10.20%), NRx Pharmaceuticals, Inc. (7.74%), PMV Pharmaceuticals, Inc. (1.95%), Akari Therapeutics, Plc (0.41%), Connect Biopharma Holdings Limited (0.14%), Mural Oncology plc (2.66%), Imunon, Inc. (33.31%), Clene Inc. (4.74%), Anebulo Pharmaceuticals, Inc. (0.13%), Barinthus Biotherapeutics plc (0.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short BioCardia stock? Short selling BCDA is an investing strategy that aims to generate trading profit from BioCardia as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioCardia? A short squeeze for BioCardia occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCDA, which in turn drives the price of the stock up even further. How often is BioCardia's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCDA, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Mersana Therapeutics Short Interest NRx Pharmaceuticals Short Interest PMV Pharmaceuticals Short Interest Akari Therapeutics Short Interest Connect Biopharma Short Interest Mural Oncology Short Interest Imunon Short Interest Clene Short Interest Anebulo Pharmaceuticals Short Interest Barinthus Biotherapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCDA) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCDA Stock Free BCDA Stock Alerts